SLC39A1 and pancreatic adenocarcinoma: To further validate the correlation between the expression levels of SLC39A1, SLC39A4, and SLC39A8 and overall survival in LIHC, CESC/PAAD, and KIRP patients, we conducted Kaplan-Meier analysis using patient cohorts obtained from the TCGA database.